Charles Scott

5.2k total citations · 2 hit papers
31 papers, 3.9k citations indexed

About

Charles Scott is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Charles Scott has authored 31 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 7 papers in Genetics. Recurrent topics in Charles Scott's work include Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (8 papers) and Lung Cancer Research Studies (8 papers). Charles Scott is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Brain Metastases and Treatment (8 papers) and Lung Cancer Research Studies (8 papers). Charles Scott collaborates with scholars based in United States, Canada and United Kingdom. Charles Scott's co-authors include Roger W. Byhardt, Todd H. Wasserman, Theodore L. Phillips, Sucha O. Asbell, Laurie E. Gaspar, Marvin Rotman, W. Gillies McKenna, Walter J. Curran, A. Rashid Dar and Hak Choy and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Journal of Urology.

In The Last Decade

Charles Scott

31 papers receiving 3.8k citations

Hit Papers

Recursive partitioning analysis (RPA) of prognostic facto... 1995 2026 2005 2015 1997 1995 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
    1997 1.9k citations Charles Scott, Marvin Rotman et al. International Journal of Radiation Oncology*Biology*Physics profile →
  2. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
    1995 541 citations Charles Scott, D. Johnson et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Scott United States 17 3.4k 2.0k 1.5k 599 398 31 3.9k
Janice Ryu United States 24 2.9k 0.9× 1.2k 0.6× 1.0k 0.7× 589 1.0× 546 1.4× 42 3.7k
A. Gregor United Kingdom 23 1.8k 0.5× 989 0.5× 600 0.4× 515 0.9× 205 0.5× 64 2.5k
Eric J. Lehrer United States 28 1.4k 0.4× 1.1k 0.5× 519 0.3× 387 0.6× 498 1.3× 118 2.7k
Jean-Paul Bahary Canada 19 2.8k 0.8× 1.0k 0.5× 1.1k 0.8× 590 1.0× 395 1.0× 104 3.3k
David E. Morris United States 20 1.3k 0.4× 774 0.4× 391 0.3× 431 0.7× 197 0.5× 50 1.9k
C. Debruyne Netherlands 24 2.4k 0.7× 1.6k 0.8× 679 0.5× 575 1.0× 228 0.6× 49 3.7k
Chad G. Rusthoven United States 29 1.7k 0.5× 1.0k 0.5× 327 0.2× 254 0.4× 272 0.7× 104 2.4k
Alba Fiorentino Italy 30 1.4k 0.4× 504 0.3× 1.0k 0.7× 441 0.7× 386 1.0× 165 2.9k
Erqi L. Pollom United States 27 1.0k 0.3× 924 0.5× 407 0.3× 537 0.9× 612 1.5× 195 2.8k
Elizabeth Gore United States 33 3.8k 1.1× 2.0k 1.0× 344 0.2× 554 0.9× 641 1.6× 133 5.2k

Countries citing papers authored by Charles Scott

Since Specialization
Citations

This map shows the geographic impact of Charles Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Scott more than expected).

Fields of papers citing papers by Charles Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Scott. The network helps show where Charles Scott may publish in the future.

Co-authorship network of co-authors of Charles Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Scott. A scholar is included among the top collaborators of Charles Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Scott. Charles Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amin, Mohammad, Oliver Brunckhorst, Charles Scott, et al.. (2020). ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma. Clinical & Translational Oncology. 23(6). 1067–1077. 18 indexed citations
2.
Scott, Charles, et al.. (2020). Managing appendicitis during the COVID-19 pandemic in the UK. British journal of surgery. 107(8). e271–e271. 9 indexed citations
3.
Amin, Mohammad, et al.. (2020). MP38-03 EFFECTS OF HAEMATOLOGICAL MALIGNANCY TREATMENT TO FERTILITY IN YOUNG MALES. The Journal of Urology. 203. e570–e570. 1 indexed citations
4.
Hartsell, William F., Charles Scott, Deborah Watkins Bruner, et al.. (2003). Phase III randomized trial of 8 Gy in 1 fraction vs. 30 Gy in 10 fractions for palliation of painful bone metastases: preliminary results of RTOG 97-14. International Journal of Radiation Oncology*Biology*Physics. 57(2). S124–S124. 13 indexed citations
5.
Cella, David, Monika Bullinger, Charles Scott, & Ivan Barofsky. (2002). Group vs Individual Approaches to Understanding the Clinical Significance of Differences or Changes in Quality of Life. Mayo Clinic Proceedings. 77(4). 384–392. 138 indexed citations
6.
Schmitt, F.A., Charles Scott, Roy A. Patchell, et al.. (2002). Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of radiation therapy oncology group (RTOG) trial BR-0018. International Journal of Radiation Oncology*Biology*Physics. 54(2). 49–49. 3 indexed citations
7.
8.
Prados, Michael D., Charles Scott, Howard M. Sandler, et al.. (1999). A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. International Journal of Radiation Oncology*Biology*Physics. 45(5). 1109–1115. 64 indexed citations
9.
Movsas, Benjamin, Charles Scott, William T. Sause, et al.. (1999). The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. International Journal of Radiation Oncology*Biology*Physics. 45(5). 1143–1149. 94 indexed citations
10.
Komaki, Ritsuko, Charles Scott, Jin S. Lee, et al.. (1997). Impact of Adding Concurrent Chemotherapy to Hyperfractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC):. American Journal of Clinical Oncology. 20(5). 435–440. 26 indexed citations
11.
Scott, Charles & Todd H. Wasserman. (1997). When is a negative study not negative?. International Journal of Radiation Oncology*Biology*Physics. 39(4). 859–861. 1 indexed citations
12.
Choucair, Ali, et al.. (1997). Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. International Journal of Radiation Oncology*Biology*Physics. 38(1). 9–20. 34 indexed citations
13.
Scott, Charles, William T. Sause, Roger W. Byhardt, et al.. (1997). Recursive partitioning analysis of 1592 patients on four radiation therapy oncology group studies in inoperable non-small cell lung cancer. Lung Cancer. 17. S59–S74. 26 indexed citations
14.
Murray, Kevin, Charles Scott, Bahman Emami, et al.. (1997). A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104. International Journal of Radiation Oncology*Biology*Physics. 39(3). 571–574. 216 indexed citations
15.
Lee, Jack, Charles Scott, Ritsuko Komaki, et al.. (1996). Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.. Journal of Clinical Oncology. 14(4). 1055–1064. 141 indexed citations
16.
Scott, Charles, D. Johnson, R. Livingston, et al.. (1995). Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 87(3). 198–205. 541 indexed citations breakdown →
17.
Nelson, Diana F., Walter J. Curran, Charles Scott, et al.. (1993). Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302. International Journal of Radiation Oncology*Biology*Physics. 25(2). 193–207. 139 indexed citations
18.
Yousem, David M., Benjamin W. Corn, Charles Scott, et al.. (1993). White matter changes are significantly correlated with rt dose: Observations from a randomized dose escalation trial for malignant glioma (RTOG 83-02). International Journal of Radiation Oncology*Biology*Physics. 27. 206–207. 1 indexed citations
19.
Murray, Kevin, Diana F. Nelson, Steven R. Isaacson, et al.. (1993). Quality adjusted survival analysis of malignant glioma patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02. International Journal of Radiation Oncology*Biology*Physics. 27. 207–207. 1 indexed citations
20.
Sause, William T., Charles Scott, Samuel G. Taylor, et al.. (1992). Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04. American Journal of Clinical Oncology. 15(2). 163–167. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janice Ryu Breakdown of academic impact, for papers by A. Gregor Breakdown of academic impact, for papers by Eric J. Lehrer Breakdown of academic impact, for papers by Jean-Paul Bahary Breakdown of academic impact, for papers by David E. Morris Breakdown of academic impact, for papers by C. Debruyne Breakdown of academic impact, for papers by Chad G. Rusthoven Breakdown of academic impact, for papers by Alba Fiorentino Breakdown of academic impact, for papers by Erqi L. Pollom Breakdown of academic impact, for papers by Elizabeth Gore
Rankless by CCL
2026